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Signal transductionThe canonical Wnt/β-catenin signaling pathway plays a central role in development and cancer. The p21-
activated kinase 4 (PAK4) involves in a wide range of cellular processes, including cytoskeletal reorganization,
cell proliferation, gene transcription and oncogenic transformation. However, the cross talk between the Wnt
and PAK4 signaling pathways is poorly understood. Here, we show that PAK4 is a nucleo-cytoplasmic shuttling
protein, containing three nuclear export signals (NESs) and two nuclear localization signals (NLSs). PAK4 is
exported by the chromosome region maintenance-1 (CRM-1)-dependent pathway and is imported into the
nucleus in an importin α5-dependent manner. PAK4 interacts with and phosphorylates β-catenin on Ser675,
which promotes the TCF/LEF transcriptional activity and stabilizes β-catenin through inhibition of its degrada-
tion. Moreover, nuclear import of PAK4 accompanies with the nuclear import of β-catenin and increased TCF/
LEF transcriptional activity. We further demonstrated that PAK4 associates with the TCF/LEF transcriptional
complex by ChIP assays. These ﬁndings uncover a novel role for PAK4 in modulating intracellular translocation
and signaling of β-catenin.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
The canonical Wnt/β-catenin signaling pathway plays a central
role in embryonic development and is also involved in a variety of
diseases [1,2]. In recent years, aberrant activation of the canonical
Wnt pathway is a hallmark of many human cancers, including the
majority of colorectal tumors and hepatocellular carcinomas [3,4].
As β-catenin is a key component of the canonical Wnt pathway, its
level and activity are tightly regulated. In the absence of Wnt ligand,
cytoplasmic β-catenin protein is constantly degraded by multi-
protein complex, which includes the scaffolding protein Axin, the
tumor suppressor adenomatous polyposis coli gene product (APC),
casein kinase 1 (CK1), and glycogen synthase (GSK3). CK1 and GSK3
sequentially phosphorylate the amino terminal region of β-catenin,
resulting in β-catenin immediate recognition and ubiquitination of
proteasomal degradation [5]. TheWnt/β-catenin pathway is activated
when a Wnt ligand binds to Frizzled (Fz or Fzd) receptor and its cor-
eceptor, low-density lipoprotein receptor-related proteins (LRP5 and
LRP6). The receptor activation inhibits β-catenin phosphorylation and
degradation, and consequently, unphosphorylated β-catenin accu-
mulates in the cytoplasm and then translocates into the nucleus
[6,7]. In the nucleus, β-catenin interacts with transcription factors of
the T-cell factor (TCF) and lymphoid enhancer factor (LEF) families,8; fax: +86 24 23261056.
gmail.com (F. Li).
rights reserved.leading to activating Wnt target genes, such as c-myc and cyclin D1
[1]. Therefore, clarifying the regulation of β-catenin signaling and
translocation is of great importance for understanding the molecular
mechanism of tumor formation.
The p21-activated kinases (PAKs) comprise a family of serine/
threonine protein kinases that were ﬁrst identiﬁed as effectors for
Rho-family GTPases. The PAKs play crucial roles in cellular processes
including cytoskeletal reorganization, motility, embryonic develop-
ment, survival and gene regulation [8]. PAKs are activated by various
extracellular signals, and through their rapidly expanding list of bind-
ing partners and kinase substrates they exert regulatory control over
essential biological processes. The mammalian PAKs are categorized
into two subgroups: group I PAKs (PAK1–PAK3) and group II PAKs
(PAK4–PAK6) [9,10]. To date, PAK4 is a representative of II PAKs
and was ﬁrst identiﬁed as a Cdc42 effector regulating ﬁlopodia forma-
tion [11]. It is now known that PAK4 involves in a wide range of
biological activities, including protecting cells against apoptosis [12],
inhibiting cell adhesion [13,14], promoting cell migration [15,16]
and anchorage-independent growth [17]. It was reported that over-
expression of PAK4 leads to tumor formation in athymic mice [18],
whereas depletion of PAK4 inhibits tumorigenesis [19]. Moreover,
ampliﬁcation or mutation of PAK4 gene has been found in different
types of cancers [19,20]. There has been evidence that PAK4 is closely
correlated to the progression and metastasis of cancer and may
become a promising diagnostic and therapeutic target for cancer
[21]. Therefore it is worthwhile to study the novel binding partners
and substrates of PAK4.
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for the regulation of the β-catenin signaling pathway by gastrins [22].
p120-catenin, the founding member of the δ-catenin family, is a
binding partner and substrate for group II PAK kinases [23]. However,
the molecular mechanism of the cross talk between the Wnt and
PAK4 signaling pathways is poorly understood.
In the current study, we investigated the nucleo-cytoplasmic
shuttling properties of PAK4. Importantly, we demonstrated that
PAK4 interacts with and phosphorylates β-catenin, which leads to
subsequent inhibition of β-catenin degradation. Therefore, our
ﬁndings demonstrate that PAK4 constitutively cycles between the
nucleus and cytoplasm and modulates the dynamic nucleo-
cytoplasmic trafﬁcking and signaling activity of β-catenin.
2. Materials and methods
2.1. Cell lines and antibodies
Human embryonic kidney (HEK) -293, African green monkey
kidney (COS-7), mouse NIH3T3, and Hela cells were maintained in
Dulbecco's modiﬁed Eagle's medium (DMEM, GIBCO, Los Angeles,
CA) supplemented with 10% fetal bovine serum (FBS), 100 units/ml
penicillin and 100 μg/ml streptomycin at 37 °C in a humidiﬁed atmo-
sphere of 5% CO2. Antibodies used were: mouse anti-GFP mAb
(GenScript Corporation), mouse anti-GST mAb (Cell Signaling), and
mouse anti-Myc mAb (Santa Cruz Biotechnology), mouse anti-α
tubulin mAb (NeoMark) and rabbit anti-Poly (ADP-Ribose) Polymer-
ase (PARP) pAb (NeoMark).
2.2. Plasmid construction and mutagenesis
Primers used for generating various wild-type and mutants are
provided in Table S1. Annealed primers were ligated into BamHI
and KpnI double enzymes digested pTetra-GFP vector to generate
pTetra-GFP-NLSs constructs. Primers were annealed to produce a
double-stranded DNA fragment and inserted into BamHI–AgeI sites
of pRev(1.4)-NES-GFP. pGEX-PAK4, Myc-PAK4 and pEGFP-PAK4
were used previously in our laboratory [16]. Mutations on PAK4 and
β-catenin were generated using the Quickchange-XL Site-Directed
Mutagenesis kit (stratagene). All constructs described above were
veriﬁed by DNA sequencing.
2.3. Cell transfection, confocal microscopy and luciferase assays
HEK-293 and COS-7 cells were seeded on glass coverslips in 12-
well plates, grown to 80–90% conﬂuence. The expression plasmids
were then transfected into the cells using Lipofectamine™ 2000 (Invi-
trogen, Carlsbad, CA, USA) according to the manufacturer's instruc-
tions. Confocal microscopy and dual-reporter assays were
determined by a previously described method [16,24].
2.4. Immunoprecipitation, western blot analysis and GST pull-down
assays
HEK-293 cells were transiently transfected with constructs of
Myc-PAK4 and pEBG-importin α5. The immunoprecipitation (IP)
procedure was performed using the Protein A Sepharose™CL-4B
(GE Healthcare, Bio-Sciences AB, Uppsala, Sweden). IP, western blot
and GST pull-down assays have been described previously in detail
[16].
2.5. Reverse transcription and quantitative real-time PCR
1 μg of total RNA was reverse transcribed to cDNA in a total vol-
ume of 20 μl using a RT (reverse transcriptase) reaction kit (Promega,
UK, Southampton, UK). Real-time PCR was performed using aStratagene Mx3000P real-time PCR system (Applied Biosystems, La
Jolla, CA) according to the manufacturer's instruction and SYBR® Pre-
mix Ex Taq (TaKaRa, Shiga, Japan) as a DNA-speciﬁc ﬂuorescent dye.
PCR was carried out for 40 cycles of 95 °C for 10 s and 60 °C for 40 s.
All the reactions were repeated at least three times. Gene expression
levels were calculated relative to the housekeeping gene β-actin by
using Stratagene Mx3000P software. The speciﬁc PCR primers are
shown in Table S2.
2.6. PAK4 kinase assay
GST-fusion proteins were puriﬁed in vitro and washed three times
with kinase buffer (50 mMHEPES, pH 7.5, 10 mMMgCl2, 2 mMMnCl2
and 0.2 mM DTT). Commercialized PAK4 Kinase (Cell Signaling Tech-
nology Inc., Beverly, MA) was used for kinase assay in 50 μl of kinase
buffer containing 10 μCi of [γ-32P] ATP (5000 Ci/mmol) for 30 min at
30 °C. Reactions were stopped by addition of 6× SDS buffer and load-
ed on a 10% SDS-PAGE. Proteins were then transferred onto PVDF
membranes and 32P-labelled proteins were visualized by autoradiog-
raphy with Molecular Imager RX (BIO-RAD, USA).
2.7. ChIP (chromatin immunoprecipitation)
HEK-293 cells in 60 mm plates were transfected with a total of
2 μg reporter plasmid (TOPFLASH or FOPFLASH), 6 μg GFP-PAK4 vari-
ant expression vectors (wild-type GFP-PAK4 or GFP-PAK4M6) or
empty vectors. After 24 h transfection, ChIP assay was done as de-
scribed [24]. Following immunoprecipitation with anti-GFP or anti-
IgG antibodies, eluted DNA was ampliﬁed by PCR. Primer pairs
were: reporter-F: AAACAAACTAGCAAAATAGG, reporter-R: CAGCG-
GATAGAATGGC; gapdh-F: TACTAGCGGTTTTACGGGCG, gapdh-R:
TCGAACAGGAGCAGAGAGCGA.
2.8. Statistical analysis
Statistical analyses were performed using SPSS version 11.0 soft-
ware. The samples were analyzed using two-sided Student's t-test. P
values b0.05 were considered signiﬁcant.
3. Results
3.1. PAK4 is a nucleo-cytoplasmic shuttling protein exported from the
nuclear through the CRM-1 pathway
Native PAK4 protein is mainly localized in cytoplasm and perinu-
cleus. To investigate the distribution of exogenous PAK4 in cells, we
analyzed the subcellular localization of PAK4 by ﬂuorescence micros-
copy using PAK4 fused with a GFP tag (GFP-PAK4) or a myc tag (Myc-
PAK4). This was done in transfected Hela cells (Fig. 1A) and COS-7
cells (data not shown). Both GFP-PAK4 andMyc-PAK4 appeared to lo-
calize predominantly within the cytoplasmic and perinucleus com-
partments and exhibit a subcellular distribution similar to that of
native PAK4 protein. The cell lysates were analyzed by western blot
with the indicated antibodies to further conﬁrm these observations
(Fig. 1B).
To examine whether the export of PAK4 depends on chromosome
region maintenance-1(CRM-1), we examined the effects of leptomy-
cin B (LMB), a speciﬁc inhibitor of CRM-1. LMB treatment resulted
in a time-dependent accumulation of GFP-PAK4 in the nucleus, with
an increase in the percentage of cells showing nuclear PAK4 staining
only half an hour after addition of LMB and reaching a maximum after
2 h exposure (Fig. 1C). These observations were conﬁrmed by west-
ern blot (Fig. 1D).
Taken together, these results indicate that the CRM-1 pathway
plays an important role in determining the nucleo-cytoplasmic shut-
tling of PAK4.
Fig. 1. Subcellular distribution of PAK4 protein. (A) The intracellular distribution of endogenous PAK4 or exogenous GFP-PAK4 or Myc-PAK4 was examined in Hela cells by confocal
ﬂuorescence microscopy. Upper panels show the distribution of PAK4 protein. Cells were counterstained with DAPI (middle panels). Lower panels show the merged images. Scale
bars: 10 μm. (B) Hela cells expressing the exogenous or endogenous PAK4 proteins were collected and fractionated into cytoplasmic (C) and nuclear extracts (N). Equal amounts of
cells from cytoplasmic and nuclear extracts were immunoblottedwith anti-GFP, anti-Myc or anti-PAK4 antibody. The efﬁciency of fractionationwas veriﬁed by staining PARP as a nuclear
marker, and β-tubulin as a cytoplasmic marker. (C) COS-7 cells transiently expressing the GFP-PAK4 fusion proteins were indicated with LMB for 0, 0.5, 2 or 4 h. The localization of GFP-
PAK4 was determined by confocal microscopy. Scale bars: 10 μm. (D) COS-7 cells expressing the GFP-PAK4 fusion proteins with or without LMB stimulation for 4 h were collected and
fractionated into cytoplasmic and nuclear extracts. Equal amounts of cells from cytoplasmic and nuclear extracts were immunoblotted with anti-GFP antibody.
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We searched for sequence motifs of PAK4 that could mediate
CRM-1-dependent export. By visual and computer-assisted inspec-
tion of the PAK4 sequences, we identiﬁed three candidate NESs
(cNESs) in PAK4. We next carried out an in vivo export assay to exam-
ine the activity of cNESs in PAK4. This assay is based on the ability of
functional NESs to restore the nuclear export of the Rev(1.4)-GFP fu-
sion protein, an NES-deﬁcient mutant of the HIV Rev protein fused
with GFP [25]. As expected, Rev(1.4)-GFP negative control was
found exclusively in the nucleus, while the positive control
Rev(1.4)-NES-GFP was only detected in the cytoplasm of COS-7 cells
(Fig. 2). The use of Actinomycin (ActD) prevents nucleolar and nucle-
ar accumulation of the Rev protein, thereby resulting in cytoplasmic
accumulation of NES-containing Rev proteins [26]. Therefore, the
use of this drug allows detection of the activity of very weak NESs.
Similar to the positive control, insertion of the wild-type PAK4
cNES[82–94] resulted in almost complete cytoplasmic relocalization
of Rev(1.4)-GFP protein. We noticed that the cNES[82–94] was highly
active and led to cytoplasmic accumulation in more than 80% of cells,
even in the absence of ActD. In addition, ActD treatment only slightly
raised the proportion of cytoplasmic Rev(1.4)-cNES[82–94]-GFP
(83.7% with ActD treatment versus 82.8% without ActD). According
to the NES scoring system [25], cNES[82–94] activity corresponds to
9+ in COS-7 cells (Table S3). Therefore, these results suggest that
the PAK4 cNES[82–94] is a strong nuclear export signal.
The wild-type cNES2 and cNES3 of PAK4 also induced cytoplasmic
relocalization of Rev(1.4)-GFP, although to a lesser extent. ActD treat-
ment raised the proportion of cytoplasmic Rev(1.4)-cNES[393–407]-
GFP and Rev(1.4)-cNES[545–554]-GFP (Fig. 2, C:7.3% and 5.6%, re-
spectively). Therefore, NES activities of both cNES[393–407] andcNES[545–554] correspond to 3+ according to the NES scoring sys-
tem (Table S3). As expected, the nuclear export activity of three
cNESs was efﬁciently blocked after LMB treatment, thus conﬁrming
CRM-1 dependence.
To further characterize the PAK4 cNESs, mutational analyses were
performed in the context of the nuclear export assay. Mutations in all
NESs resulted in less nuclear export activity comparing with the wild-
type cNESs (Fig. 2).3.3. Mutational inactivation of the NES1 in the context of full-length
PAK4
Following the above observations, we next examined the role of
the NES[82–94] in the full-length PAK4. We generated a series of
cNES[82–94] mutants substituting alanines for leucine, valine, pro-
line, or methionine in the context of the full-length PAK4 protein
using site-directed mutagenesis (Fig. S1A). We noted that L82A
(Leucine at 82 was replaced with alanine), L84A and L86A did not
change the subcellular localization, whereas other mutants, L85A,
V94A, and L84AL85A (M3, M7 and M8 mutants, respectively) led to
a minor but signiﬁcant nuclear enrichment comparing with the
wild-type protein. Intriguingly, the mutants of F89A and M92A
almost completely abolished nuclear export, indicating that the F89
and M92 residues were crucial for nuclear export (Fig. S1B).
For the wild-type protein and each mutant (M1–M8), the fold of
accumulation in the nucleus induced by LMB was calculated as the
ratio of [N/N+C(+LMB)]/ [N/N+C(−LMB)] (Fig. S1C and S1D). As
expected, the M1, M2 and M4mutants displayed the same or a slight-
ly lower sensitivity to LMB treatment comparing to the wild-type
protein. In contrast, other mutants were less responsive to LMB.
Fig. 2. The analysis of NES activity of PAK4 using an in vivo nuclear export assay. COS-7 cells were transfected with pRev-1.4-GFP or various pRev-NES-GFP constructs and their
subcellular localization was analyzed by ﬂuorescence microscopy. Left panels show representative images. Right panels show histograms presenting the percentage of cells for
each condition that exhibits only cytoplasmic (C), nuclear plus cytoplasmic (NC) or exclusively nuclear (N) GFP ﬂuorescence staining. Approximately 100 cells were scored for
each transfection experiment. Data represents mean values of three independent experiments with standard deviations. Scale bars: 10 μm.
468 Y. Li et al. / Biochimica et Biophysica Acta 1823 (2012) 465–475Together, the 82-LLLDEFENMSV-94 motif is a functional NES that is
required for CRM-1-dependent nuclear export of PAK4.
3.4. The PAK4 NLS exhibits an import activity in a Tetra-GFP reporter system
The PAK4 amino acid sequences were analyzed with a NLS
recognizing program, PSORTII. To investigate the functional signiﬁcanceof these candidateNLSs (cNLSs),we examined themusing the tetra-GFP
reporter system. Conventional EGFP reporter constructs failed to unam-
biguously demonstrate NLS functionality, due to its passive diffusion
into the nucleus; the tetra-GFP reporter system was developed to
prevent passive diffusion, which has been established as a reliable
method [27,28]. Tetra-GFP itself was predominantly localized in the
cytosol, while the tetra-GFP-tagged SV40-NLS, a known functional NLS
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ly, Tetra-GFP-cNLS [4–7], which carries the cNLS1 sequence of PAK4
protein, was totally localized in the nucleus, while Tetra-GFP-cNLS
[158–161], carrying the cNLS3 sequence of PAK4 protein, was localized
not only in the nucleus, but also in the cytoplasm. In contrast, both
Tetra-GFP-cNLS[48–51] and Tetra-GFP-cNLS[470–473] were localized
in the cytoplasm (Fig. S2). On the other hand, we selectively mutated
each cNLS by replacing the basic lysine residue with alanine. The resul-
tant mutations of all cNESs were localized in the cytoplasm. These
results demonstrate that the cNLS1 of the PAK4 is a strong nuclear
localization signal and the cNLS3 of the PAK4 may be a weak nuclear
localization signal.
To further precisely determine the amino acid responsible for nu-
clear import, site-directed mutagenesis was performed to substitute
lysine and arginine with alanine in the context of the full-length
PAK4 protein (Fig. S3A). Mutations in the NLS of PAK4 did not
remarkably reduce the nuclear localization of the mutated proteins,
comparing with the wild-type PAK4 (percentage of nuclear
localization, WT: 30.2±6.1%; M9: 24.7±5.3%; M10: 20.7±0.6%;
M11: 25.6±3.7%; M12: 24.0±0.6%; M13: 23.5±3.2%; M14: 23.7±
5.5; M15: 24.7±4.8%) (Fig. S3B). One possibility is that a reduction
of the nuclear activity of PAK4 NLS motif might not be easily detected
without inhibiting PAK4 nuclear export. Therefore, we examined the
subcellular localization of the cNLS1-mutated and cNLS3-mutated
GFP-PAK4 proteins after LMB treatment (Fig. S3B). GFP-PAK4 pro-
teins bearing mutations in the NLS motif accumulated in the nucleus
to a lesser extent than the wild-type protein after LMB treatment,
which indicated that the nuclear import of these NLS mutants was al-
ready changed. Among these mutations M9 and M10 led to a signiﬁ-
cant decrease in nuclear localization when compared with other
mutants. These ﬁndings suggest that 4-KRKK-7 and 158-KRPK-161
motifs act as true NLSs in the context of PAK4 protein.
3.5. The interaction of PAK4 with importin α5 depends on cNLS1 and
cNLS3
Proteins that contain classical NLSs are imported into the nucleus
by importin α/β heterodimers. In mammalian cells, six importin α
family members have been identiﬁed which belong to three subfam-
ilies: the Rch1 subfamily (importin α1/Rch1), the Qip subfamily
(importin α3/Qip1 and importin α4/Qip2), and the NPI-1 subfamily
(importin α5/NPI-1, importin α6, and importin α7/NPI-2) [29]. To in-
vestigate whether PAK4 is recognized by any of these importin proteins,
we performed in vitro binding assays using puriﬁed GST-importins
(importin α1, α3, α5 and β), representing each of the subgroups of
importin α and βmolecules. As shown in Fig. 3A, PAK4 efﬁciently inter-
acted with GST-importin α5 but not with empty GST, GST-importin α1,
α3 orβ in GST pull-down assays. Conversely, in vitro-translated importin
α5 also speciﬁcally interacted with GST-PAK4 (Fig. 3B). We next exam-
ined whether PAK4 interacts with importin α5 in vivo by immunopre-
cipitation assay. Results indicated that GST-importin α5 was
immunoprecipitated along with Myc-PAK4, demonstrating that impor-
tin α5 and PAK4 were present in the same protein complex (Fig. 3C).
These results demonstrate that PAK4 physically associateswith importin
α5 in vitro and in vivo.
We next searched for the importin α5-binding region in PAK4. Pu-
riﬁed GST-fused PAK4 NLS deletion constructs were used in a GST
pull-down assay with recombinant importin α5 (Fig. 3D). We found
that PAK4 region containing cNLS1 or cNLS3 could speciﬁcally bind
importin α5, while the PAK4 region that contains cNLS2 or cNLS4
only could not. These data indicated the interaction of PAK4 with
importin α5 depends on cNLS1 and cNLS3.
Then we compared the binding activities of PAK4 NLSmutants and
wild-type to importin α5. Results showed that NLS mutant PAK4 (M9
and M10) have a weaker afﬁnity with importin α5 than wild-type
(Fig. 3E).3.6. PAK4 interacts with and phosphorylates β-catenin on Ser675
Immunoprecipitation was performed to test whether β-catenin is
a binding partner of PAK4. Endogenous PAK4 coimmunoprecipitated
with endogenous β-catenin in the COS-7 cells (Fig. 4A), demonstrat-
ing that PAK4 and β-catenin proteins interact with each other in
vivo. To further examine whether the interaction between PAK4 and
β-catenin is direct or indirect, we performed in vitro GST pull-down
assays (Fig. 4B). The binding of PAK4 and β-catenin was detected,
demonstrating that PAK4 could directly interact with β-catenin.
Because PAK4 is a serine/threonine kinase, we next examined
whether β-catenin is a substrate of PAK4. To map the PAK4 phosphor-
ylation site(s) on β-catenin, we ﬁrst determined the region of β-
catenin that was phosphorylated by PAK4 by using GST-fusion pro-
teins of various domains of β-catenin. The histone H3, an established
PAK4 substrate, and GST were used as positive and negative controls,
respectively. The results showed that PAK4 efﬁciently phosphorylated
histone H3 but not GST in vitro kinase assays (Fig. 4C). PAK4 speciﬁ-
cally phosphorylated the β-catenin C1 domain (667–781aa) but failed
to phosphorylate β-catenin N1 (1–130aa) and N2 (131–318aa) do-
mains. While the detectable levels of phosphorylated β-catenin
could be found in β-catenin N3 (319–666aa) and β-catenin C2
(531–666aa). These results suggested that PAK4 selectively phos-
phorylates β-catenin at C-terminal amino acids 319–781. Examina-
tion of β-catenin aa 319–781 revealed two potential PAK4
phosphorylation sites, serine 552 and serine 675. Single-point muta-
tion of either serine to alanine substitutions was used to examine
the function. The result showed that PAK4 could phosphorylate
wild-type full-length β-catenin, and the phosphorylation was largely
abrogated by mutation on Ser675 but not on Ser552 (Fig. 4D). These
results demonstrate that β-catenin can be phosphorylated by PAK4
on Ser675 in vitro.
3.7. Phosphorylation of β-catenin by PAK4 promotes transcriptional ac-
tivity of β-catenin
To understand functional signiﬁcance of β-catenin phosphorylation
by PAK4, we ﬁrst examined how the PAK4-dependent phosphorylation
of β-catenin affects its transcriptional activity using TCF/LEF-luciferase
reporter. Overexpression of wild-type PAK4 (PAK4WT) or constitutively
active PAK4 (PAK4NE) stimulated TCF/LEF transcriptional activity by
≈6-fold comparing with control vector, but this effect was attenuated
by kinase-inactive PAK4 (PAK4KM) (Fig. 5A). These results indicate
that PAK4 enhances TCF/LEF transcriptional activity in a kinase
activity-dependent fashion. Furthermore, mutation of β-catenin at
S675Amarkedly reduced the PAK4-enhancing effect of TCF/LEF reporter
activity, in contrast to wild-type β-catenin (Fig. 5B). Therefore, our re-
sults raise the possibility that PAK4 promotes the TCF/LEF activity in-
duced by β-catenin, at least in part, through phosphorylation of
β-catenin on Ser675.
3.8. Phosphorylation of β-catenin by PAK4 stabilizes β-catenin through
inhibition of its degradation
We examined whether the PAK4-dependent phosphorylation of
β-catenin may modulate its stability. As shown in Fig. 5C, in COS-7
cells after treatments with cycloheximide (CHX), a speciﬁc protein
synthesis inhibitor for various time, β-catenin had a short half-life
of less than 2 h in cells transfected with control vector. In cells trans-
fected with PAK4WT or PAK4NE, we observed a signiﬁcantly en-
hanced half-life of β-catenin compared with the control vector. In
contrast, PAK4KM markedly reduced β-catenin protein levels com-
paring with wild-type PAK4 or PAK4NE. Taken together, these results
suggest that β-catenin phosphorylation by PAK4 inhibit its
degradation.
Fig. 3. The interaction of PAK4 with importin α5 depends on cNLS1 and cNLS3. (A) For GST pull-down assay, GST or GST-importin fusion proteins were incubated with PAK4 protein
in vitro translated. Schematic representation of the deletion constructs of PAK4 is shown. (B) Importin α5 protein translated in vitro was incubated with either GST or GST-PAK4
fusion proteins using GST pull-down assay. (C) For the immunoprecipitation assay, HEK-293 cells transfected with Myc-PAK4 and pEBG-importin α5 were lysed. Lysates were
immunoprecipitated with GST or IgG antibody and immunoblotted with anti-Myc or anti-GST antibody. (D) GST-PAK4 deletion proteins were incubated with importin α5 in
vitro-translated by GST pull-down assay. (E) GST-PAK4 wild-type and mutation proteins were incubated with importin α5 in vitro-translated by GST pull-down assay. Asterisks
indicated the GST-fusion protein bands, and Ponceau stain indicated the loading amounts for GST-fusion proteins.
Fig. 4. PAK4 interacts with and phosphorylates β-catenin on Ser675. (A) Immunoprecipitation of the lysates from HEK-293 cells with a β-catenin or control IgG antibody was ex-
amined by western blot using antibodies against PAK4 or β-catenin. (B) In vitro-translated β-catenin was incubated with GST or GST-PAK4 fusion proteins by GST pull-down assays.
(C) In vitro phosphorylation of β-catenin by PAK4. Puriﬁed GST or various GST-β-catenin deletion fusion proteins were used as PAK4 substrates in PAK4 kinase assay and histone H3
(HH3) served as a positive control. Different domains of β-catenin have been shown schematically. (D) Puriﬁed wild-type full-length β-catenin, β-catenin S552A and S675A mu-
tations were used as PAK4 substrates in PAK4 kinase assay. Ponceau stain of the GST-fusion proteins was used in the assay.
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Fig. 5. Phosphorylation of β-catenin by PAK4 enhances β-catenin signaling and inhibits its degradation. (A) COS-7 cells were transfected with cDNAs for TCF-luciferase reporters
(TOPFLASH or FOPFLASH) along with a control plasmid (tk-RL) and with cDNAs for empty vector, PAK4WT, PAK4NE or PAK4KM. After 24 h transfection, reporter activity was mea-
sured as described under “Materials and methods”. (B) COS-7 cells were transfected with the indicated constructs. The luciferase activities were measured. The data present the
mean±sd from three experiments. (C) COS-7 cells were transfected with cDNAs for empty vector, PAK4WT, PAK4NE or PAK4KM together with β-catenin. After 24 h transfection,
the cells were treated with 10 μg/ml CHX for indicated time. Cell lysates were analyzed by western blot with antibodies against β-catenin, Myc or GAPDH. (D) COS-7 cells were
transfected with the indicated constructs. The cell lysates were analyzed by western blot with antibodies against β-catenin, Myc or GAPDH.
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protein stability of wild-type β-catenin and its PAK4 phosphorylation
mutant β-catenin S675A. The cells transfected were harvested at var-
ious time interval of CHX treatment, and Fig. 5D showed that β-
cateninS675A degraded more rapidly as compared with wild-type
β-catenin. These results support the notion that β-catenin Ser675
phosphorylation by PAK4 increases β-catenin stability.
To determine whether PAK4 modulates β-catenin protein levels
via proteasome-dependent degradation, the 26S proteasome inhibi-
tor MG132 was used to block the β-catenin protein degradation.
MG132 resulted in a stabilization of β-catenin in the cells transfected
with PAK4WT together with wild-type β-catenin or β-cateninS675A
mutant (Fig. 5D). These results suggest that phosphorylation of
β-catenin by PAK4 inhibits β-catenin degradation via a proteasome-
dependent pathway.
3.9. Nucleo-cytoplasmic PAK4 modulates the subcellular distribution of
β-catenin
We tested whether nucleo-cytoplasmic shuttling of PAK4 affects
the subcellular distribution of β-catenin. β-catenin-S33Y, a mutant
of β-catenin resistant to degradation, was distributed equally in thenucleus and the cytoplasm when transfected with EGFP empty vector
(Fig. 6A and B). In the cells expressing β-catenin-S33Y with wild-type
PAK4, the percentage of cytoplasmic β-catenin increased compared
with EGFP empty vector. By contrast, the percentage of nuclear
β-catenin was increased by the co-expression of M6. These results
suggest that nucleo-cytoplasmic PAK4 has a regulatory function in
β-catenin intracellular translocation.
3.10. Role of nuclear PAK4 in β-catenin signaling
To assess whether the nuclear-cytoplasmic shuttling of PAK4 di-
rectly regulates β-catenin signaling, we performed luciferase reporter
assays. First, we evaluated the effects of different NES or NLS mutants
of PAK4 on the TCF/LEF transcriptional activity. The wild-type PAK4
upregulated the TCF/LEF transcriptional activity and PAK4 cNES1 mu-
tant (M6 or Del1) had a stronger effect than the wild-type, while
cNLS1 mutant (M9 or M10) had a weaker effect than the wild-type
(Fig. 7A). This suggests that the nuclear accumulation of PAK4 could
enhance β-catenin-dependent transcription.
Then we examined whether the nuclear accumulation of PAK4
regulates β-catenin expression. As show in Fig. 7B, wild-type PAK4
slightly upregulated β-catenin expression, while M6 markedly
Fig. 6. Nucleo-cytoplasmic PAK4 modulates the subcellular distribution of β-catenin. (A) Representative images of NIH3T3 cells transiently transfected with the constructs expres-
sing β-catenin-S33Y alone or β-catenin-S33Y with wild-type GFP-PAK4, M6 or Del1 mutants. β-catenin was visualized with an FITC-conjugated antibody, and the nucleus was
stained with DAPI. Scale bars: 10 μm. (B) Quantiﬁcation of the cells according to the localization of β-catenin protein.
Fig. 7. Role of nuclear PAK4 in β-catenin signaling and translocation. (A) COS-7 cells were transfected with cDNAs for TCF-luciferase reporters (TOPFLASH or FOPFLASH) along with
tk-RL and with cDNAs for empty vector, PAK4WT, or various NLS or NES mutants of PAK4. Dual Luciferase Reporter assay was examined. Data presents the mean±sd from three
experiments. (B) COS-7 cells were transfected with EGFP, PAK4WT or M6mutant. After 24 h transfection, cell lysates were blotted for β-catenin, GFP or GAPDH expression. (C) COS-
7 cells were transfected with siRNAs targeting PAK4 or non-silencing control. After 48 h of transfection, the protein level of PAK4, β-catenin, cyclin D1 and c-myc was measured by
western blot. (D) COS-7 cells were transfected with cDNAs for empty vector, PAK4WT or M6, and the mRNA level of cyclin D1 and c-myc was estimated by real-time PCR. COS-7
cells were transfected with siRNAs targeting PAK4 or non-silencing control along with or without wild-type β-catenin, and the mRNA level of cyclin D1 and c-myc was estimated by
real-time PCR (bottom panel). (E) HEK-293 cells were transfected with various combinations of plasmids encoding PAK4WT or M6 together with the TOPFLASH or FOPFLASH. ChIP
assay was carried out using antibody against GFP, followed by PCR with primers amplifying the reporter vectors or GAPDH.
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characterized targets, cyclin D1 and c-myc, both of which were en-
hanced with concomitant upregulation of β-catenin. We next used
PAK4-speciﬁc siRNA to block the expression of endogenous PAK4
gene product. The efﬁciency of RNAi was examined by western blot.
As shown in Fig. 7C, the effective knockdown of PAK4 reduced the
protein levels of β-catenin, cyclin D1 and c-myc expression.
We next investigated whether the differing subcellular localiza-
tion of PAK4 may affect Wnt/β-catenin target genes on the mRNA
level. As shown in Fig. 7D, cells over-expressing wild-type PAK4 in-
duced the expression of cyclin D1 ~46.4% and c-myc ~64.5% com-
pared with control vector, while cells over-expressing M6 had a
stronger effect of upregulating their mRNA levels than wild-type
PAK4. Furthermore, as shown in Fig. 7D, silencing of PAK4 reduced
mRNA expression of cyclin D1 18.9% and c-myc 24.8% compared
with the non-silencing control, respectively. After transfecting wild-
type β-catenin, in the PAK4 knockdown sample the mRNA level of cy-
clin D1 and c-myc was downregulated 37.1% and 31.1%, respectively,
compared with the sample without the knockdown. This suggests
that PAK4 could affect β-catenin-dependent transcription in mamma-
lian cells.
To further study the role of the nuclear PAK4 in modulation of
β-catenin signaling, we examined the physical interaction of PAK4
with the reporter plasmid. As shown in Fig. 7E, wild-type PAK4 was
immunoprecipitated with the reporter plasmid TOPFLASH, but not
with the control plasmid FOPFLASH. In contrast to wild-type PAK4,
M6 enhanced its binding to the reporter plasmid TOPFLASH. These re-
sults suggest a positive role for nuclear PAK4 in the modulation of
β-catenin-mediated gene expression.4. Discussion
The Wnt/β-catenin signaling pathway has been implicated in nu-
merous stages of development and pathophysiology of different dis-
eases, including cancer, Alzheimer's disease and bone density
syndromes [3]. β-catenin, a key component of Wnt pathway is often
mutated or otherwise dysregulated in a variety of human cancers.
For these reasons, obtaining a better understanding of the nuclear
and cytoplasmic trafﬁcking of β-catenin is of great clinical importance
and can be exploited as a therapeutic target for cancer and other
diseases.
In this study, we show that PAK4 is a nuclear-cytoplasmic shut-
tling protein capable of cycling back and forth between nucleus and
cytoplasm. Subcellular localization of PAK4 is thought to be regulated
by the balance between nuclear import and export. To determine the
presence of NLSs and NESs in PAK4, we adopted strategies as follows:
ﬁrst to predict NLS and NES motifs in PAK4 protein by bioinformatics
methods; second to use two speciﬁc detection systems, Rev-GFP and
Tetra-GFP systems; and ﬁnally, to detect point mutations in the full-
length PAK4 protein for further conﬁrmation. PAK4 nuclear export
is mediated by three NES motifs through CRM-1/exportin pathway.
And among three NES motifs cNES1 plays a decisive part in PAK4 nu-
clear export. On the other hand, two PAK4 NLS motifs, cNLS1 and
cNLS3, may be responsible for PAK4 nuclear accumulation. While
this work was in progress, an independent study by Siu has been pub-
lished showing that PAK4 has two NLS motifs, NLS1 and NLS3 [21].
These ﬁndings are consistent with our results, although the methods
and cell lines in the current study were different. Moreover, our data
also demonstrated that NLS1 is a strong nuclear localization signal.
One question remains whether PAK4 nuclear import utilizes the clas-
sical importin-α/β nuclear import mechanism. The in vitro binding
and coprecipitation assays demonstrated that PAK4 physically inter-
acts with importin α5 and the interaction is dependent on NLS1 or
NLS3. In support of these ﬁndings, PAK4 constitutively travels be-
tween the nucleus and cytoplasm.Nucleo-cytoplasmic transportation of proteins has an important
role in cell function. Nucleo-cytoplasmic shuttling of PAK5 regulates
its antipoptotic properties [30,31]. Therefore, it will be worthwhile
to further elucidate the nucleo-cytoplasmic shuttling functions of
PAK4. When we searched for binding protein of PAK4, we found
that β-catenin could physically interact with PAK4 in mammalian
cells. Based on this observation, we hypothesized that PAK4 could
phosphorylate β-catenin. Kinase assay showed that PAK4 phosphory-
lates β-catenin on Ser675. We speculated that Ser675 site is the main
β-catenin phosphorylation site in response to PAK4 kinase, although
we cannot completely rule out the existence of other phosphorylation
sites. Our results demonstrate that β-catenin is a substrate and bind-
ing partner of PAK4. Further evidence showed that β-catenin Ser675
phosphorylation by PAK4 promotes its transcription activity and in-
hibits its degradation. As previously demonstrated, phosphorylation
of β-catenin on Ser675 by protein kinase A inhibits its ubiquitination,
resulting in the accumulation of β-catenin and the activation of Tcf-4
[32]. It was reported that β-catenin Ser675 phosphorylation facili-
tates the interaction between β-catenin and CBP [33]. Recently, Liu
reported β-catenin phosphorylation on Ser675 in pancreatic β cells
can be activated by the incretin hormone glucagons-like peptide-1
[34]. It is reported that a Rac1/PAK1 cascade controls β-catenin
S675 phosphorylation and full activation in colon cancer cells [35].
We conclude that PAK4-dependent stabilization of β-catenin is at
least partly due to the inhibition of the degradation of β-catenin
through β-catenin Ser675 phosphorylation by PAK4. The exact mo-
lecular mechanism by which PAK4 inhibits the degradation of
β-catenin is unknown at present. It is possible that PAK4 interacts
with some ubiquitin ligase or PAK4 facilitates the escaping of
β-catenin from the destruction complex.
Our studies suggested that nuclear accumulation of PAK4 en-
hances nuclear import of β-catenin. However, previous studies
showed that β-catenin accumulation in the cells does not always in
the activation of β-catenin-mediated gene expression. For example,
co-expression of β-catenin with cFLIP-S increased the cellular level
of β-catenin, meanwhile β-catenin-mediated gene expression was
not induced by the co-expression of cFLIP-S [36]. In our study, we
found that nuclear accumulation of PAK4 can promote catenin/TCF-
medicated gene transcription and upregulate β-catenin expression.
We summarized that PAK4 promotes catenin/TCF-medicated gene
transcription by three ways: (1) Phosphorylation of β-catenin by
PAK4 promotes TCF/LEF gene transcription; (2) Nuclear accumulation
of PAK4 accompanies with the increased nuclear β-catenin, resulting
in increased TCF/LEF-medicated gene transcription; (3) Nuclear accu-
mulation of PAK4 upregulates β-catenin expression, leading to TCF/
LEF-medicated gene transcription. To date, most studies have concen-
trated on PAK4 cytoplasmic function, but little is known about PAK4
nuclear function. PAK1 was found to translocate to the nucleus
upon EGF stimulation, and nuclear PAK1 interacts with the PFK-M
and NFAT1 chromatin and regulates their gene transcriptions [37].
Here we present a novel nuclear role of PAK4 which promotes TCF/
LEF gene transcription by modulating β-catenin signaling. The associ-
ation of PAK4 with β-catenin further stimulates the expression of
c-myc and cyclin D1 leading to cell proliferation. Siu has reported
that PAK4 overexpression induced cell proliferation through the
PAK4/c-Src/EGFR pathway that controls cyclin D1 and CDC25A ex-
pression [21]. Here we present a novel mechanism for PAK4 underlying
cell proliferation by promoting β-catenin/TCF signaling. Furthermore,
PAK4 interacts with TOPFLASH reporter plasmid in the nucleus
(Fig. 7E), suggesting that PAK4 associateswith a transcriptional complex
in β-catenin-mediated gene expression. However, there are still some
limitations in this present study, the potential of extracellular signals
which activate this pathway should be further studied.
In summary, our results support this model and provide a poten-
tial mechanism that PAK4 modulates Wnt signaling by two mecha-
nisms: (1) in the cytoplasm, PAK4 phosphorylation of β-catenin on
Fig. 8.Model of nucleo-cytoplasmic shuttling PAK4 modulates β-catenin translocation and signaling. In our model, we propose that PAK4 is a nucleo-cytoplasmic shuttling protein
mediated by NESs and NLSs. PAK4 is exported by the CRM-1-dependent pathway and is imported into the nucleus in an importin α5-dependent manner. Moreover, PAK4 interacts
with and phosphorylates β-catenin, which inhibits its degradation and increases β-catenin-dependent transcriptional activity. Accumulation of nuclear PAK4 accompanies
β-catenin nuclear import and increases β-catenin-dependent TCF/LEF transcriptional activity.
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and (2) in the nucleus, PAK4modulatesβ-catenin signaling by associating
with the transcriptional complex (Fig. 8). We herein unravel a novel role
for PAK4 signaling bymodulation of phosphorylation andnuclear translo-
cation of β-catenin, leading to β-catenin/TCF-mediated gene expression
of cyclin D1 and c-myc which contributes to the development of cancer.
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